Placeholder Banner

BIO Signs on to Multi-Industry Letter Supporting Critical Infrastructure in Wake of COVID-19 Outbreak

March 25, 2020

In the wake of the COVID-19 outbreak, the Biotechnology Innovation Organization (BIO) joins 111 industry groups across sectors in a letter to federal, state and local lawmakers supporting uniform definitions of "critical infrastructure" as outlined by the Department of Homeland Security and it's Cybersecurity and Infrastructure Security Agency. 

Complete and total adoption of these definitions as a floor across the country will ensure much-needed manufacturers can continue to operate, transport products and have a workforce available. If not adopted widely, curfews that do not consider transportation and workforce needs could quickly become significant barriers to not only supply chains, but also actual supplies. 

To help in the exchange of resources and manufacturing capacity as companies focus on addressing the pandemic, BIO has created the Coronavirus Hub. The hub allows researchers and companies to share their extra capacity and resources with companies that need them. Visit the Coronavirus Hub at hub.bio.org/landing-page/community-home

Download Full Comments Below
Multi Industry Letter Supporting DHS CISA Critical Infrastructure Definitions
Discover More
The Biotechnology Innovation Organization appreciates the opportunity to comment on the Center for Medicare and Medicaid Services’ Information Collection Request on the Part C and Part D Medicare Prescription Payment Plan Model Documents.
In response to the 340B Request for Information issued by the Senate 340B Bipartisan Working Group, BIO submits detailed comments.
We are writing to express our strong support for the bipartisan Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act). The legislation, which was introduced by Reps. John Joyce (R-PA) and Wiley Nickel (D-NC) in September,1 corrects a…